In cancer type stratification analysis, the CASP8 -652 6N ins/del polymorphism decreased risk for colorectal cancer, breast cancer, esophageal cancer, renal cell carcinoma, lung cancer, cervical cancer, bladder cancer, gastric cancer, and other cancers. Here, CASP8 is linked to breast carcinoma.